Poland· PL-100503526
Pazopanib TZF
A pazopanib product containing pazopanibum, registered in Poland by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pazopanib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX03 (pazopanib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Pazopanib · ATC L01EX03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pazopanib costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pazopanib · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$87.69
The record
At a glance
URPL (Poland)- Active substance
- Pazopanibum
- Manufacturer
- Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- Country
- Poland (PL)
- ATC code
- L01EX03
- ATC class
- Pazopanib
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05904016060674
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
593 interactions on record for pazopanib.
Graded by severity as the source publishes them — 155 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pazopanib · interactions on record
593 records
- 155 severe
- 428 moderate
- 10 minor
Most severe, free to view
- CimetidineA02BA01severe
- RanitidineA02BA02severe
- FamotidineA02BA03severe
- NizatidineA02BA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pazopanib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPAZOPANIB ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- FinlandPazopanib AccordAccord Healthcare B.V.
- NetherlandsPazopanib Accord 400 mg filmomhulde tablettenAccord Healthcare B.V.
- FrancePAZOPANIB ACCORD 400 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- SwedenPazopanib Accord 400 mg Filmdragerad tablettAccord Healthcare B.V.
- IrelandPazopanib Accord 400 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- SpainPAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGAccord Healthcare S.L.U.
- BelgiumPazopanib Accord 400 mgAccord Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Pazopanib Devatis
- Belgium · Pazopanib Accord, Pazopanib Eg
- Bulgaria · Алуниб, Пазопаниб G.L. Pharma
- Cyprus · Pazopanib Sapiens, Pazorem
- Czechia · Pazopanib Accord, Pazopanib Sandoz
- Germany · Pazopanib Al, Pazopanib Beta
- Denmark · Pazopanib Accord, Pazopanib Glenmark
- Estonia · Pazopanib Accord, Pazopanib Teva
- Spain · Pazopanib Accord, Pazopanib Dr. Reddys
- Finland · Pazopanib Accord, Pazopanib Glenmark
- France · Pazopanib Accord, Pazopanib Biogaran
- United Kingdom (Northern Ireland) · Pazopanib Accord, Pazopanib Accord Healthcare
- Greece · Pazopanib Accord, Pazopanib Stada
- Croatia · Pazopanib Accord, Pazopanib Frontier
- Hungary · Pazopanib Accord, Pazopanib G.L. Pharma
- Ireland · Pazopanib Accord, Pazopanib Reddy
- Iceland · Pazopanib Adalvo, Pazopanib Stada
- Italy · Pazopanib Accord, Pazopanib Dr. Reddy’s
- Liechtenstein · Votrient
- Lithuania · Pazopanib Accord, Pazopanib Auxilia
- Luxembourg · Pazopanib Eg, Pazopanib Pazopanib Eg
- Latvia · Pazopanib Accord, Pazopanib Teva
- Malta · Pazopanib Pharmacare, Pazopanib Pharos
- Netherlands · Pazopanib Accord, Pazopanib Cf
- Norway · Pazopanib Accord, Pazopanib Glenmark
- Portugal · Pazopanib Accord, Pazopanib Bluepharma
- Romania · Pazopanib Accord, Pazopanib Dr. Reddys
- Sweden · Pazopanib Accord, Pazopanib Glenmark
- Slovenia · Pazopanib Accord, Pazopanib Teva
- Slovakia · Pazopanib Accord, Pazopanib G.L. Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5a4d2752-f64c-46a7-a90d-1f8ea26663e9 GET /v1/drugs/5a4d2752-f64c-46a7-a90d-1f8ea26663e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "400 mg",
"packaging": "05904016060674 ¦ Rpz ¦ 163960\n30 tabl.",
"substance": "Pazopanibi hydrochloridum 433.4 mg",
"common_name": "Pazopanibum",
"pl_product_id": "100503526",
"pozwolenie_nr": "29538",
"auth_procedure": "DCP",
"authorisation_validity": "2031-02-19"
}See everything about pazopanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.